Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

Fu, Chen; Yu, Lifeng; Miao, Yuxi; Liu, Xinli; Yu, Zhaojin; Wei, Minjie.

Afiliação

Fu C; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.
Yu L; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China.
Miao Y; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.
Liu X; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.
Yu Z; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China.
Wei M; Liaoning Medical Diagnosis and Treatment Center, Shenyang 110000, China.

Acta Pharm Sin B ; 13(2): 498-516, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36873165